Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: A population-based study

Journal of Alzheimer's Disease

Volumn 31, Issue 3, 2012, Pages 669-676

  Wallin, Karin ^a   Solomon, Alina ^a,b   Kreholt, Ingemar ^a   Tuomilehto, Jaakko ^c,d   Soininen, Hilkka ^b   Walin, Karin ^a,b,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Alzheimer's disease; cognitive impairment; dementia; epidemiology; inflammation; joint disorders; longitudinal; rheumatoid arthritis

Indexed keywords

ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E4; CELECOXIB; GLUCOCORTICOID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTHROPATHY; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COGNITIVE DEFECT; DEMENTIA; DISEASE ASSOCIATION; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

EID: 84865585052     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-111736     Document Type: Article

References (34)

1. Gorelick PB (2010) Role of inflammation in cognitive impairment: Results of observational epidemiological studies and clinical trials. Ann NY Acad Sci 1207, 155-162.
2. Jenkinson ML, Bliss MR, Brain AT, ScottDL (1989) Rheumatoid arthritis and senile dementia of the Alzheimer's type. Br J Rheumatol 28, 86-88.
3. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, Raskind M (1990) A case-control study of Alzheimer's Disease. Ann Neurol 28, 766-774.
4. McGeer PL, McGeer E, Rogers J, Sibley J (1990) Antiinflammatory drugs and Alzheimer disease. Lancet 335, 1037.
5. Myllykangas-Luosuj̈arvi R, Isom̈aki H (1994) Alzheimer's disease and rheumatoid arthritis. Br J Rheumatol 33, 501-502.
6. Beard CM, Kokman E, Kurkland LT (1991) Rheumatoid arthritis and susceptibility to Alzheimer's disease. Lancet 337, 1426.
7. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC (1990) A case-control study of Alzheimer's disease in Australia. Neurology 40, 1698-1707. (Pubitemid 20383135)
8. Li G, Shen YC, Li YT, Chen CH, Zhau YW, Silverman JM (1992) A case-control study of Alzheimer's disease in China. Neurology 42, 1481-1488.
9. French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B (1985) A case-control study of dementia of the Alzheimer type. Am J Epidemiol 121, 414-421. (Pubitemid 15128176)
10. Breitner JC, Gau BA, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44, 227-232. (Pubitemid 24070956)
11. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T (1984) Alzheimer's disease: A study of epidemiological aspects. Ann Neurol 15, 335-341. (Pubitemid 14139468)
12. The Canadian Study of Health and Aging (1994) Risk factors for Alzheimer's disease in Canada. Neurology 44, 2073-2080.
13. Kivipelto M, Helkala EL, Ḧanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A (2001) Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology 56, 1683-1689. (Pubitemid 32574567)
14. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12, 189-198.
15. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56, 303-308. (Pubitemid 29120227)
16. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edn. American Psychiatric Association, Washington, DC.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944. (Pubitemid 14076461)
18. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, Kurokawa K, Teramoto T (1993) Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 121, 598-602. (Pubitemid 23112654)
19. Rovio S, K°areholt I, Helkala EL, Viitanen M, Winblad B, Tuomilehto J, Soininen H, Nissinen A, Kivipelto M (2005) Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease. Lancet Neurol 4, 705-711. (Pubitemid 41457285)
20. Dziedzic T (2006) Systemic inflammatory markers and risk of dementia. Am J Alzheimers Dis Other Dement 21, 258-262. (Pubitemid 44291132)
21. Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ (2009) Microglial activation and amyloid deposition in mild cognitive impairment: A PET study. Neurology 72, 56-62.
22. Eikelenboom P, Veerhuis R, van Exel E, Hoozemans JJM, Rozemuller AJM, van Gool WA (2011) The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: Neuropathological, epidemiological and genetic evidence. Curr Alzheimer Res 8, 142-150.
23. Simmons CR, Zou F, Younkin SG, Estus S (2011) Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease. Mol Neurodegener 6, 33.
24. Del Rinćon I, Williams K, Stern MP, Freeman GL, Escalante A (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional risk factors. Arthritis Rheum 107, 1303-1307.
25. Salpeter SR, Gregor P, Ormiston TM, Whitlock R, Raina P, Thabane L, Topol EJ (2006) Meta-analysis: Cardiovascular events associated with nonsteroidal anti-inflammatory drugs. Am J Med 119, 552-559. (Pubitemid 44063485)
26. Agency for Healthcare Research and Quality (2010) Alzheimer's disease and cognitive decline, http://www.ahrq. gov/clinic/tp/alzcogtp.htm.
27. Szekely CA, Thorne JE, Zandi PP, Ek M, Messias E, Breitner JC, Goodman SN (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: A systematic review. Neuroepidemiology 23, 159-169. (Pubitemid 38980441)
28. Szekely CA, Breitner JC, Fitzpatrick AL, Rea TD, Psaty BM, Kuller LH, Zandi PP (2008) NSAID use and dementia risk in the Cardiovascular Health Study: Role of APOE and NSAID type. Neurology 70, 17-24.
29. Breitner JC, Haneuse SJ, Walker R, Dublin S, Crane PK, Gray SL, Larson EB (2009) Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 72, 1899-1905.
30. ADAPT Research Group, Lyketsos CG, Breitner JC, Green RC, Martin BK, Meinert C, Piantadosi S, Sabbagh M (2007) Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 68, 1800-1808. (Pubitemid 46791392)
31. ADAPT Research Group, Martin BK, Szekely C, Brandt J, Piantadosi S, Breitner JC, Craft S, Evans D, Green R, Mullan M (2008) Cognitive function over time in the Alzheimer's disease anti-inflammatory prevention trial (ADAPT): Results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol 65, 896-905. (Pubitemid 352008472)
32. Breitner JC, Baker LD, Montine TJ, Meinert CL, Lyketsos CG, Ashe KH, Brandt J, Craft S, Evans DE, Green RC, Ismail MS, Martin BK, Mullan MJ, Sabbagh M, Tariot PN ADAPT Research Group (2011) Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement 7, 402-411.
33. Kaipiainen-Sepp̈anen O, Aho K, Nikkarinen M (2001) Regional differences in the incidence of rheumatoid arthritis in Finland in 1995. Ann Rheum Dis 60, 128-132. (Pubitemid 32102203)
34. Pieringer H, Pichler M (2011) Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: Vascular alterations and possible clinical implications. QJM 104, 13-26.